How to Get Enclomiphene Citrate in Washington State

What Is Enclomiphene Citrate and Why Washington Men Use It

Enclomiphene is the trans-isomer of clomiphene, and it stimulates the hypothalamic-pituitary axis to raise endogenous testosterone without suppressing sperm production. Unlike exogenous testosterone therapy, it preserves fertility. Kim et al. enrolled 124 men with secondary hypogonadism and found that enclomiphene 25 mg daily normalized serum testosterone in 75.8% of participants at 16 weeks while maintaining sperm counts, compared with suppressed spermatogenesis in the testosterone-gel control arm 1.

Washington State has seen growing demand for this approach. Men who want to maintain fertility while correcting low testosterone, and men who have not tolerated topical or injectable testosterone, are the two groups most likely to benefit. The American Urological Association's 2018 guidelines on male hypogonadism note that selective estrogen receptor modulators are an acceptable off-label option for secondary hypogonadism in men who wish to preserve fertility 2.

No FDA-approved oral enclomiphene product is currently marketed in the United States, a status that the FDA's drug database confirms 3. All prescriptions dispensed in Washington are filled by 503A compounding pharmacies preparing patient-specific formulations under state and federal compounding law.

Washington State Legal Framework for Prescribing Enclomiphene

Washington law permits licensed physicians (MD and DO), nurse practitioners with prescriptive authority, and physician assistants to prescribe compounded medications for individual patients. The Washington State Department of Health confirms that prescribers may authorize 503A compounded drugs when a commercially available equivalent is absent or clinically unsuitable 4. Enclomiphene satisfies that threshold because no finished-dosage-form product is currently on formulary.

Telehealth prescribing is fully authorized. The Washington Uniform Telehealth Act (RCW 70.290) allows prescribers licensed in Washington to conduct synchronous video evaluations and issue valid prescriptions, including for compounded drugs. The prescription does not require an in-person visit first, provided the provider conducts a real-time audio-video encounter and documents a clinical rationale 5.

Prescribers must still comply with federal rules. The DEA does not schedule enclomiphene, so no controlled-substance prescribing number is needed beyond a standard DEA registration for the practice.

Required Labs Before Getting an Enclomiphene Prescription in Washington

Every reputable Washington prescriber will require a baseline hormone panel before writing the first prescription. Ordering labs first, not after, protects both the patient and the prescriber if a prior-authorization request follows.

The minimum recommended panel draws from Endocrine Society guidance on male hypogonadism 6:

• Total testosterone (two morning draws on separate days, collected between 7 a.m. and 10 a.m.)
• LH and FSH (to confirm secondary rather than primary hypogonadism)
• Estradiol (sensitive assay preferred)
• Sex hormone-binding globulin (SHBG) and calculated free testosterone
• Prolactin (to rule out a pituitary adenoma driving low LH)
• CBC and comprehensive metabolic panel
• PSA for men over 40 or with risk factors

The Endocrine Society's 2018 clinical practice guideline states: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs consistent with testosterone deficiency and unequivocally low serum testosterone concentrations" 6. That two-draw rule matters. A single low value drawn at 2 p.m. does not meet the diagnostic standard and will likely be rejected during prior authorization.

Secondary hypogonadism is confirmed when total testosterone is below 300 ng/dL (some guidelines use 264 ng/dL) alongside low or inappropriately normal LH and FSH. Enclomiphene works by blocking estrogen receptors in the hypothalamus, increasing GnRH pulse frequency, and thereby raising LH, FSH, and downstream testosterone synthesis 7.

Quest Diagnostics and LabCorp both operate patient service centers across Washington, and most telehealth platforms can send electronic lab requisitions to either network. Results typically return within 24 to 48 hours for routine hormone panels.

How to Get an Enclomiphene Prescription Through Telehealth in Washington

Washington telehealth providers follow a straightforward sequence. Complete the intake form and upload existing lab results or consent to a new lab order. Attend a synchronous video visit, typically 20 to 30 minutes, with a licensed Washington prescriber. Receive the prescription electronically. The pharmacy ships the compound directly to your Washington address.

HealthRX connects Washington patients with board-certified physicians who specialize in men's hormonal health. The HealthRX Washington intake pathway runs on the following decision structure:

1. Labs first. The platform sends a lab requisition to a Washington-accessible draw site or uses uploaded results dated within 90 days.
2. Video consult. A Washington-licensed MD or DO reviews the labs, symptom checklist, and relevant history live on video.
3. Prescription routing. If clinically appropriate, the prescriber sends a patient-specific compounding order to a Washington-licensed 503A pharmacy.
4. Shipment. The pharmacy compounds the capsules and ships with overnight or two-day carrier service.
5. Follow-up at 6 to 8 weeks. A repeat testosterone and LH draw confirms therapeutic response and guides dose adjustment.

This structure keeps the prescriber in control of clinical decision-making at each step and ensures the lab evidence exists before any medication is dispensed. Patients with a prior secondary hypogonadism diagnosis and labs from another Washington provider may transfer those records to skip the initial draw, shortening the process by two to three days.

503A Compounding Pharmacies in Washington: What Patients Need to Know

Because no FDA-approved enclomiphene tablet is on the market, Washington patients receive compounded enclomiphene prepared by a 503A pharmacy. Section 503A of the Federal Food, Drug, and Cosmetic Act authorizes licensed pharmacists to compound drugs for individual patients based on a valid prescription 8. The pharmacy must hold an active Washington State pharmacy license, maintain USP 795 standards for non-sterile compounding, and source active pharmaceutical ingredient from an FDA-registered supplier.

Enclomiphene citrate is typically compounded as an oral capsule at 12.5 mg or 25 mg strengths. Some pharmacies offer a scored troche or sublingual tablet, though oral capsule form is the most widely prescribed format in Washington. Monthly costs run roughly $60 to $120 for a 30-day supply at 25 mg daily, depending on the pharmacy's pricing and whether insurance applies.

Washington 503A pharmacies may ship across state lines as long as the receiving patient holds a valid prescription. If you are a Washington resident whose prescriber is located in another state, the pharmacist still needs a valid Washington-compliant prescription. The FDA's guidance on 503A compounding clarifies that interstate shipment is permissible under federal law when state law does not specifically prohibit it 8.

USP Chapter 795 sets minimum beyond-use dating for non-sterile oral compounded solids at 180 days when stored at controlled room temperature, which gives Washington patients adequate time to use a 90-day supply before expiration 9.

Washington Medicaid and Insurance Coverage for Enclomiphene

Washington Apple Health (Medicaid) may cover enclomiphene citrate for secondary hypogonadism, though the indication is off-label. Coverage requires prior authorization, and the clinical documentation standard is strict.

The prior authorization file should include:

• Diagnosis code E23.0 (hypopituitarism) or E29.1 (testicular hypofunction) as appropriate
• Two documented morning testosterone values below 300 ng/dL with corresponding low or inappropriately normal LH
• A statement from the prescriber explaining why FDA-approved testosterone products are not appropriate (fertility preservation is a commonly accepted reason)
• The proposed dose, dosage form, and treatment duration

Washington Medicaid's Preferred Drug List does not list any oral enclomiphene product, which means every request goes to non-preferred drug review 10. Approval rates improve significantly when the chart documents at least two failed or intolerable courses of approved testosterone therapy or a documented fertility preservation goal.

Commercial insurers in Washington, including Premera, Regence, and Kaiser Foundation Health Plan of Washington, handle enclomiphene coverage individually. Most classify it as not covered because no FDA-approved formulation exists, and they exclude compounded drugs from standard pharmacy benefits. Appealing on the basis of medical necessity with supporting trial data, such as the Kim 2016 BJU Int findings, can sometimes succeed 1.

Dosing, Titration, and Monitoring After Starting Enclomiphene in Washington

The standard starting dose used in Washington telehealth practice is 12.5 mg to 25 mg orally once daily, taken in the morning with or without food. The Kim et al. 2016 trial used 12.5 mg and 25 mg arms and found the 25 mg dose produced a mean total testosterone of 570 ng/dL at 16 weeks (baseline mean 247 ng/dL), a 131% increase from baseline 1.

A second key study by Wiehle et al. (Andrology, 2014, N=18) demonstrated that enclomiphene 12.5 mg daily raised mean testosterone from 230 ng/dL to 404 ng/dL after four weeks while LH increased from 3.1 to 6.0 IU/L, confirming the central mechanism of action 11.

Monitoring schedule after prescription fill:

• Week 6 to 8. Total testosterone (morning), LH, estradiol. Target testosterone 400 to 700 ng/dL.
• Week 12. Semen analysis if fertility preservation is the primary goal.
• Month 6. CBC (to check hematocrit, which rises less dramatically with enclomiphene than with exogenous testosterone), lipid panel, PSA in appropriate age groups.

Estradiol elevation is the most common reason for dose reduction. Enclomiphene's anti-estrogenic effect at the pituitary partially limits estradiol rise, but some men with high baseline aromatase activity still develop elevated estradiol above 40 pg/mL 12. Dose reduction to 12.5 mg or addition of a low-dose aromatase inhibitor (anastrozole 0.5 mg twice weekly) addresses this in most cases.

The Endocrine Society notes that clomiphene and its isomers carry a theoretical risk of visual disturbances at higher doses, though this adverse effect is far more common in women using clomiphene for ovulation induction than in men at the doses used for hypogonadism 13. Patients should report any changes in vision promptly.

Transferring an Existing Enclomiphene Prescription to Washington

Men relocating to Washington with an active enclomiphene prescription from another state can transfer that prescription under specific conditions. The original prescriber must be licensed in Washington or must write a new prescription once the patient establishes Washington residency. An out-of-state prescription is valid at a Washington 503A pharmacy only if the original prescriber holds an active Washington license 14.

The most practical path for patients who have moved: book a telehealth consult with a Washington-licensed provider, bring the prior lab work and prescription records, and request a new prescription based on the existing documentation. Most telehealth providers can complete this in a single video visit when labs are current (within 90 days) and the clinical picture is unchanged.

Patients already stable on enclomiphene rarely need a full re-workup. A prescriber with access to the prior testosterone and LH results can confirm ongoing secondary hypogonadism status and issue a Washington-valid prescription the same day as the consult.

Comparing Enclomiphene to Other Secondary Hypogonadism Options Available in Washington

Washington prescribers can choose among several approaches for secondary hypogonadism, and understanding why enclomiphene is selected over alternatives helps patients make informed decisions.

Clomiphene citrate (Clomid, generic) contains both the trans-isomer (enclomiphene) and the cis-isomer (zuclomiphene). Zuclomiphene has a longer half-life and has been associated with estrogenic side effects and persistent visual changes at higher doses. Using the purified trans-isomer (enclomiphene) reduces that estrogenic burden while preserving the LH-stimulating effect 15.

Testosterone replacement therapy (TRT), using gels (AndroGel, Testim), injectables (testosterone cypionate 100 to 200 mg every one to two weeks), or subcutaneous pellets, raises serum testosterone but suppresses LH and FSH through negative feedback, leading to testicular atrophy and azoospermia within three to six months in most men 16. For a Washington man who wants children within the next two to three years, TRT is generally contraindicated as a first-line choice.

Human chorionic gonadotropin (hCG) directly stimulates Leydig cells and is often combined with TRT to preserve testicular volume, but it requires subcutaneous injection and costs significantly more than oral enclomiphene. Monthly hCG costs in Washington run $200 to $400 compared with $60 to $120 for compounded enclomiphene capsules.

The AUA guideline recommends discussing all options, including selective estrogen receptor modulators, with patients who have secondary hypogonadism and fertility goals before starting exogenous testosterone 2.

Side Effects and Contraindications Relevant to Washington Patients

Enclomiphene is generally well tolerated at the doses used for male hypogonadism. The most commonly reported adverse effects in the Kim 2016 trial (N=124) were headache (8.1%), nausea (4.0%), and mood variability (3.2%) 1. These rates were not statistically different from placebo at P<0.05.

Absolute contraindications include active liver disease (enclomiphene undergoes hepatic metabolism), known hypersensitivity to clomiphene or its isomers, and primary hypogonadism (the drug requires an intact pituitary-gonadal axis to work). Men with primary testicular failure, diagnosed by elevated LH and FSH alongside low testosterone, will not respond to enclomiphene and should not receive it.

Relative contraindications include elevated PSA without urological clearance, uncontrolled polycythemia, and a history of hormone-sensitive malignancy. Washington prescribers routinely screen for these at the baseline visit. A baseline PSA above 4 ng/mL typically requires urology referral before proceeding 17.

Drug interactions are limited. Enclomiphene is metabolized primarily by CYP3A4, so potent CYP3A4 inhibitors (ketoconazole, clarithromycin) may increase plasma levels, and inducers (rifampin, carbamazepine) may reduce efficacy 18. Prescribers in Washington should review the full medication list at the intake visit.

What to Expect: Timeline From First Inquiry to First Dose in Washington

The end-to-end timeline for most Washington patients runs seven to fourteen days when starting from scratch, or three to five days when carrying current labs.

Day 1 to 2. Complete the telehealth intake form and schedule a video consult, or visit a Washington draw site for baseline labs.

Day 2 to 4. Lab results return (Quest or LabCorp standard turnaround is 24 to 48 hours for testosterone panels).

Day 4 to 5. Video consult with a Washington-licensed prescriber, prescription sent electronically to the compounding pharmacy.

Day 5 to 7. Pharmacy compounds and ships the 30-day supply using two-day carrier service.

Day 7 to 9. Capsules arrive at the Washington address.

Men who already have qualifying labs dated within 90 days can compress this to three to five days total. The video consult itself is the rate-limiting step for same-day or next-day prescription approval.

Washington residents in rural areas (eastern Washington, Olympic Peninsula, and the San Juan Islands) benefit most from the telehealth pathway, since driving to an endocrinologist in Seattle or Spokane for a first consultation may add weeks of wait time. The telehealth model eliminates geographic barriers entirely and ships directly to a residential address regardless of ZIP code.